EFFICACY OF GUSELKUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE NOT IN CLINICAL RESPONSE AT WEEK 12: RESULTS FROM THE GALAXI 1 STUDY

Remo Panaccione  1     Anita Afzali  2     Geert R. D'Haens  3     Leonardo Salese  4     Natalie Terry  4     Aparna Sahoo  4     Mary Ellen Frustaci  4     Zijiang Yang  4     Eran Zittan  5, 6     Silvio Danese  7     Tadakazu Hisamatsu  8    
1 University of Calgary, Calgary, Canada
2 University of Cincinnati, Cincinnati, United States
3 Amsterdam University Medical Centre, Amsterdam, Netherlands
4 Janssen Research & Development, LLC, Spring House, United States
5 Emek Medical Center, Afula, Israel
6 The Rappaport Faculty of Medicine Technion-Israel Institute of Technology, Haifa, Israel
7 IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milano, Italy
8 Kyorin University, Tokyo, Japan

Topic
Endoscopy, Histopathology, IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing